France Pet Nutraceuticals Market Size and Share

France Pet Nutraceuticals Market Analysis by Mordor Intelligence
The France pet nutraceuticals market was valued at USD 180.82 million in 2025 and is projected to grow from USD 188.87 million in 2026 to USD 261.14 million by 2031, registering a CAGR of 6.82% during 2026-2031. The market is driven by consistent demand for preventive pet health products, increased veterinary involvement in supplement selection, and the growing use of science-based functional ingredients in daily pet care routines. Regulatory frameworks play a significant role, as ingredient approvals and claim positioning are governed by European Union feed additive regulations and national oversight by the Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES). This emphasizes the importance of compliance-focused product development. The market is also benefiting from the growth of digital retail platforms, which allow brands to effectively communicate the purpose of ingredients, product formats, and clinical support, surpassing the limitations of traditional in-store displays. Additionally, the expansion of the French e-commerce sector is further supporting this trend. Competition in the market is balanced among multinational pet care companies, French animal health specialists, and ingredient-focused suppliers. This competitive landscape fosters innovation in areas such as probiotics, omega-3 products, and specialized formulations targeting mobility, digestion, skin health, and immune support. Overall, the France pet nutraceuticals market continues to favor companies that integrate veterinary expertise, species-specific formulations, and strategic product launches within the European Union's regulatory framework.
Key Report Takeaways
- By sub product, the France pet nutraceuticals market share for vitamins and minerals accounted for the largest 26.6% in 2025, and it is projected to expand at the fastest 7.3% CAGR from 2026 to 2031.
- By pets, cats held the largest 44.1% share in 2025, while the France pet nutraceuticals market size for dogs is forecast to grow at the fastest CAGR of 7.4% from 2026 to 2031.
- By distribution channel, supermarkets/hypermarkets captured the largest 65.2% share in 2025, while the online channel is projected to grow at the fastest CAGR of 8.0% from 2026 to 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
France Pet Nutraceuticals Market Trends and Insights
Drivers Impact Analysis*
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Pet humanization and preventive wellness spending | +1.4% | National, with stronger traction in major urban centers | Long term (≥ 4 years) |
| Aging pet population and chronic condition management | +1.2% | National, strongest where veterinary access is dense | Medium term (2-4 years) |
| Veterinary-recommended supplement adoption | +1.0% | National, led by metropolitan veterinary networks | Long term (≥ 4 years) |
| Premium and functional product trade-up | +0.9% | National, strongest in specialty retail and digital channels | Medium term (2-4 years) |
| Expanding condition-specific digital commerce assortments | +0.8% | National, led by e-commerce-active regions | Short term (≤ 2 years) |
| Rising cat-specific health formulations demand | +0.7% | National, aligned with France’s cat-focused pet base | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Pet Humanization and Preventive Wellness Spending
The market is supported by a growing emphasis on preventive pet care over occasional treatment. This trend facilitates the integration of supplements into daily wellness routines, addressing areas such as digestion, immunity, skin, coat, and mobility. The European Pet Food Industry Federation (FEDIAF) Nutritional Guidelines 2025 further promote this approach by offering species-specific nutrient recommendations in European countries such as France. These guidelines enhance formulation credibility, nutritional balance, and product development practices within the pet care industry. As a result, manufacturers can shift from general wellness claims to more precise nutritional support, boosting consumer trust and encouraging the regular use of nutraceutical products in long-term pet wellness programs.
Aging Pet Population and Chronic Condition Management
The nutraceuticals industry is experiencing growth due to increasing focus on age-related health conditions in companion animals, particularly those impacting mobility, joint function, and overall quality of life. As pets live longer, owners are more inclined to include nutritional supplements in daily care routines to promote long-term wellness and healthy aging. Products featuring omega-3 fatty acids, collagen derivatives, antioxidants, and other functional ingredients are being increasingly adopted as part of preventive health strategies. According to Virbac S.A., 90% of cats over 10 years old exhibit clinically significant joint issues, highlighting the demand for mobility-focused nutritional support in countries like France[1]Source: Virbac S.A., “The Future of Cat Mobility Starts Now,” virbac.com.. This trend is driving sustained demand for senior-oriented pet nutraceutical products, where increasing pet longevity and greater awareness of preventive pet healthcare continue to encourage the adoption of age-specific nutritional solutions.
Veterinary-Recommended Supplement Adoption
The market is experiencing growth driven by the significant role of veterinarians in influencing pet healthcare decisions and the increasing adoption of supplements. Veterinarians' professional recommendations assist pet owners in choosing specialized products aimed at improving digestive health, immunity, mobility, and healthy aging. Regulatory oversight enhances trust in science-based formulations by ensuring that ingredients used in companion animal nutrition comply with established safety and quality standards. In September 2025, the European Commission approved Bifidobacterium longum CNCM I-5642 as a feed additive for dogs, providing regulatory validation for this probiotic strain in countries such as France[2]Source: European Commission, “Commission Implementing Regulation (EU) 2025/1776 of 8 September 2025 Authorising a Preparation of Bifidobacterium longum CNCM I-5642 as a Feed Additive for Dogs,” eur-lex.europa.eu.. This approval facilitates the broader commercialization of microbiome-focused nutraceutical solutions across the European Union, supporting markets like France, where demand for scientifically validated companion animal health products continues to rise.
Premium and Functional Product Trade-Up
Growing consumer interest in premium products that provide targeted nutritional and functional health benefits. Whereas, pet owners are increasingly seeking formulations that support digestive wellness, mobility, immunity, skin condition, and healthy aging, encouraging manufacturers to expand science-based product portfolios. This shift is helping move the market beyond basic supplementation toward more specialized and condition-specific solutions. According to GlobalPETS, the French pet food industry reported a turnover of EUR 4.8 billion (USD 5.6 billion) in 2024, up from EUR 4.1 billion (USD 4.8 billion) in the previous year, demonstrating consumers' willingness to spend more on higher-value pet nutrition products and supporting demand for premium nutraceutical formulations.
Restraints Impact Analysis*
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Limited consumer trust in supplement efficacy claims | -0.8% | National, stronger in value-oriented markets | Medium term (2-4 years) |
| Regulatory scrutiny on functional ingredient positioning | -0.6% | National, linked to ANSES and European Union review processes | Long term (≥ 4 years) |
| Price sensitivity outside premium pet owner cohorts | -0.5% | National, strongest in mass retail channels | Short term (≤ 2 years) |
| Fragmented brand differentiation and private label substitution | -0.4% | National, most visible in grocery-led formats | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Limited Consumer Trust in Supplement Efficacy Claims
Ongoing challenges regarding consumer confidence in the efficacy of supplements, particularly those marketed for long-term wellness benefits rather than immediate, observable results. Pet owners often approach claims related to digestive health, immunity, mobility support, and healthy aging with caution, as the effectiveness of such products can be difficult to evaluate over short timeframes. This underscores the critical role of veterinary endorsements, scientific validation, transparent communication, and brand reputation in influencing purchasing decisions. Products lacking robust evidence or credible professional support tend to see slower adoption, especially in digital channels where consumers can easily compare competing claims. Consequently, established brands with strong scientific credibility maintain a competitive edge over newer entrants in the market.
Regulatory Scrutiny on Functional Ingredient Positioning
The industry encounters challenges stemming from the time and expenses involved in introducing new functional ingredients under the European regulatory framework. Producers of innovative nutritional solutions are required to meet extensive documentation, safety assessment, and regulatory approval requirements prior to commercialization. This process lengthens development timelines and increases market entry costs, especially for emerging bioactives, postbiotics, and specialized protein ingredients. Regulation (EC) No 1831/2003, which governs additives for animal nutrition within the European Union, outlines a structured approval process aimed at ensuring product safety. However, this also introduces regulatory complexity and higher entry barriers. These requirements can delay the launch of innovative companion animal nutraceutical products in France and impose significant compliance burdens, particularly on smaller manufacturers with limited resources for regulatory and clinical validation activities.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Segment Analysis
By Sub Product: Vitamins And Minerals Lead Across Life Stages
The France pet nutraceuticals market share for vitamins and minerals held the largest 26.6% in 2025. This segment leads due to the widespread use of vitamins and minerals in various daily wellness applications, such as immune support, healthy aging, metabolic balance, and nutritional reinforcement. Their versatility allows manufacturers to create products catering to different life stages and health conditions. Additionally, strong consumer familiarity with these ingredients simplifies product communication compared to more specialized nutraceutical components. This combination drives consistent demand across veterinary, specialty retail, and mainstream pet care channels.
Vitamins and minerals are forecast to grow at the fastest 7.3% CAGR from 2026 to 2031. This growth is driven by rising demand for targeted nutritional solutions aimed at companion animal wellness and preventive care. Manufacturers are increasingly developing formulations tailored to specific physiological needs, such as mobility, immunity, skin health, and age-related support. Vitamins and minerals also integrate seamlessly with broader nutraceutical formulations, enhancing their relevance across multiple product categories. Their established scientific backing, regulatory acceptance, and suitability for routine supplementation position this segment for sustained growth within the market.

By Pets: Cat Ownership Shapes Product Development Priorities
Cats accounted for the largest 44.1% share in 2025. This segment benefits from France's substantial feline population and the increasing demand for species-specific nutritional care. Cat owners are progressively seeking products tailored to meet unique physiological needs, such as urinary health, digestive support, coat maintenance, and healthy aging. This trend drives manufacturers to focus on feline-specific formulations, enhance product palatability, and develop convenient delivery formats. Additionally, heightened consumer awareness regarding preventive pet care further bolsters demand in this category. Consequently, cats remain the leading contributor to value generation within the market.
The France pet nutraceuticals market size for dogs is projected to grow at the fastest CAGR of 7.4% from 2026 to 2031. Increasing interest in solutions for mobility support, cognitive wellness, digestive health, and active aging is driving the adoption of nutraceuticals among dog owners. Product developers are diversifying their offerings with condition-specific formulations tailored to various breeds, life stages, and activity levels. Veterinary recommendations significantly influence consumer trust and encourage repeat purchases. These factors are expanding the addressable market and enhancing long-term growth opportunities for dog-focused nutraceutical products in France.
By Distribution Channel: Online Gains Speed While Grocery Holds Scale
Supermarkets/Hypermarkets led with the largest share at 65.2% in 2025. This dominance is attributed to their extensive geographic presence, established consumer trust, and the convenience of combining pet care purchases with routine household shopping. These retail formats offer broad product visibility, enabling nutraceutical brands to reach a wide customer base. Additionally, shelf presence in mainstream stores enhances consumer awareness and encourages trial purchases among pet owners unfamiliar with specialized supplement categories. As a result, supermarkets and hypermarkets remain the leading sales channel in the market.
The online channel is projected to grow at the fastest CAGR, 8.0%, from 2026 to 2031. Digital platforms provide consumers with access to detailed product information, ingredient transparency, customer reviews, and subscription purchasing options that support recurring demand. Furthermore, online channels allow brands to reach customers beyond the physical locations of veterinary clinics and specialty retailers. The ability to compare formulations, access educational content, and explore a wider product assortment enhances consumer engagement and drives growth in this segment.

Geography Analysis
France encompasses the entire geographic scope of the pet nutraceuticals market within the country and benefits from having one of the largest companion animal populations in Europe. The market is bolstered by a robust veterinary infrastructure, high awareness of preventive pet healthcare, and the widespread availability of premium pet products through both retail and professional channels. Increasing consumer interest in wellness-oriented nutrition continues to drive the adoption of supplements targeting mobility, digestive health, immunity, and healthy aging. National oversight, combined with European regulatory requirements, ensures high product quality standards, fostering trust among manufacturers, veterinarians, retailers, and pet owners.
Demand for pet nutraceuticals is particularly strong in urban and suburban areas, where access to veterinary services, specialty pet retail networks, and digital purchasing platforms is more advanced. These factors enhance consumer exposure to condition-specific nutraceutical products and encourage repeat purchases. The growing role of e-commerce further supports this trend by providing access to educational content, ingredient details, and product comparisons, enabling consumers to make informed purchasing decisions. Consequently, manufacturers are increasingly adopting multichannel strategies that integrate veterinary recommendations, specialty retail presence, and digital engagement to enhance market penetration across various regions in France.
France benefits from a well-established companion animal care ecosystem, supported by veterinary services, specialty pet retail networks, and rising consumer interest in preventive nutrition. Pet owners are increasingly seeking products that address mobility, digestive health, immunity, and healthy aging, prompting manufacturers to expand their condition-specific nutraceutical offerings. The country also provides a conducive environment for innovation, backed by established regulatory oversight and heightened awareness of animal wellness. According to GlobalPETS, referencing the 2024 pet population survey conducted by the Fédération des Fabricants d'Aliments pour Chiens, Chats, Oiseaux et autres animaux familiers (FACCO), France had 16.7 million cats in 2024, underscoring sustained demand for species-specific nutritional products and supplement innovation[3]Source: GlobalPETS, “French Pet Market (I): Pet Ownership Steady as Population Hits 75 Million,” globalpetindustry.com..
Competitive Landscape
The French pet nutraceuticals market is moderately consolidated, with key players including Mars, Incorporated, Nestlé S.A., Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company), Virbac S.A., and Vetoquinol S.A. Competition in the market is increasingly focused on science-based nutritional solutions addressing specific health concerns in companion animals, such as digestive health, mobility support, immune function, and healthy aging. Established companies maintain market leadership through strong veterinary relationships, extensive distribution networks, and recognized brand portfolios. Meanwhile, emerging players are targeting niche formulations and specialized health applications to attract pet owners seeking tailored wellness solutions.
France’s advanced veterinary infrastructure and the growing emphasis on preventive pet healthcare significantly influence competitive strategies within the market. Manufacturers are prioritizing investments in clinically validated ingredients, improved product palatability, and convenient delivery formats to enhance acceptance and drive repeat purchases. Veterinary endorsement remains a crucial factor in shaping purchasing decisions, particularly for premium nutraceutical products. Additionally, compliance with European regulatory standards, scientific validation of health claims, and effective engagement through veterinary clinics, specialty pet stores, and e-commerce platforms are becoming increasingly vital for maintaining competitive advantage and strengthening market positioning in France.
Strategic initiatives focus on species-specific product development, evidence-based ingredient selection, and channel expansion, rather than price competition. France-based Vetoquinol S.A. reported Essential Products sales of EUR 334.5 million (USD 362 million) in 2025, accounting for 64% of its total annual sales. This underscores the growing commercial significance of wellness-oriented and complementary animal health solutions in the global market including France. The strong performance of this segment reflects rising demand for preventive care products and sustained investment in companion animal health innovation. This trend highlights the adoption of scientifically validated nutraceutical solutions and emphasizes the role of premium, health-focused products in driving growth within France's companion animal nutrition market.
France Pet Nutraceuticals Industry Leaders
Mars, Incorporated
Nestlé S.A.
Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company)
Virbac S.A.
Vetoquinol S.A.
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- September 2025: Virbac S.A. launched Vikaly, the first medicated feed for cats worldwide. This product integrates a therapeutic renal diet with veterinary medicine to improve treatment adherence for cats with chronic kidney disease, aligning with the increasing emphasis on specialized feline nutrition and veterinary-led health management in France.
- January 2025: In collaboration with Emmyon, Inc., Virbac S.A. introduced URSOLY Soft Chews for Dogs, a nutritional supplement aimed at supporting skeletal muscle health and strength in aging, active, and recovering dogs. This launch enhances access to targeted healthy-aging solutions and bolsters innovation in companion animal nutraceuticals in France.
- September 2024: Virbac S.A. also launched MOVOFLEX Soft Chews for Cats, broadening its companion animal nutraceutical portfolio with a feline-specific mobility supplement. This product is designed to promote joint health and support healthy movement in cats, further advancing science-based mobility and preventive care solutions in France.
France Pet Nutraceuticals Market Report Scope
Pet nutraceuticals are functional nutritional products designed to enhance pet health beyond basic dietary needs. These include vitamins, probiotics, omega-3 fatty acids, and bioactive compounds that support immunity, digestion, joint health, skin condition, and overall well-being. The France Pet Nutraceuticals Market Report is Segmented by Sub-Product (Milk Bioactives, Omega-3 Fatty Acids, Probiotics, Proteins and Peptides, Vitamins and Minerals, and More), by Pets (Cats, Dogs, and Other Pets), and by Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets and Hypermarkets, and More). The Market Forecasts are Provided in Terms of Value (USD) and Volume (Metric Tons).
| Milk Bioactives |
| Omega-3 Fatty Acids |
| Probiotics |
| Proteins and Peptides |
| Vitamins and Minerals |
| Other Nutraceuticals |
| Cats |
| Dogs |
| Other Pets |
| Convenience Stores |
| Online Channel |
| Specialty Stores |
| Supermarkets/Hypermarkets |
| Other Channels |
| By Sub Product | Milk Bioactives |
| Omega-3 Fatty Acids | |
| Probiotics | |
| Proteins and Peptides | |
| Vitamins and Minerals | |
| Other Nutraceuticals | |
| By Pets | Cats |
| Dogs | |
| Other Pets | |
| By Distribution Channel | Convenience Stores |
| Online Channel | |
| Specialty Stores | |
| Supermarkets/Hypermarkets | |
| Other Channels |
Key Questions Answered in the Report
What is the 2031 outlook for France pet nutraceuticals?
The France pet nutraceuticals market is projected to reach USD 261.14 million by 2031.
Which sub product leads demand in France?
Vitamins and Minerals led with the largest 26.6% share in 2025 and also remained the fastest growing sub product category through the forecast period.
Why are cat-focused supplements important in France?
Cats accounted for the largest 44.1% share in 2025, and feline product design matters because cats need more specific nutrition and higher palatability than dogs.
Which sales channel is expanding the fastest?
The online channel is the fastest growing route, with an 8.0% CAGR from 2026 to 2031.
Page last updated on:




